Media & Resources

Most recent

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

IAVI 2024 Annual Report

An overview of the progress IAVI and partners made in 2024 toward our pursuit to translate scientific discoveries into affordable, globally accessible public health solutions.

Read more

Workshop report: Financing TB vaccines R&D – African priorities, needs and stakeholder perspectives

In this report, we synthesize key insights and recommendations across three thematic areas that emerged during the workshop, convened on 19 June 2025 at the 12th EDCTP Forum in Kigali, Rwanda. The workshop brought together 20 experts from diverse global and regional institutions to explore the priorities, needs, and perspectives of African stakeholders to enhance support of TB vaccine research and development R&D.

Read more

Workshop report: Towards a proposal for a novel TB vaccine R&D financing initiative

This report captures the key insights from a roundtable discussion, convened on 14 October 2024 at the World Health Assembly in Berlin, Germany, focused on innovative financing mechanisms to support the late-stage development of tuberculosis (TB) vaccines. The session aimed to harness expert perspectives on potential financing strategies and criteria that could be applied to TB vaccine development, with three thematic recommendations emerging.

Read more

Technical brief: Towards a proposal for a novel TB vaccine R&D financing initiative

This brief outlines key considerations and tentative recommendations towards a new financing initiative for TB vaccines R&D, with a focus on late-stage candidates. It is designed to provide background information to help stimulate debate during the workshop series on late-stage TB vaccine R&D financing R&D. The contents of this paper and the outputs of the workshop series, which includes engagement with a range of key stakeholders, will inform the development of a validated proposal for late-stage TB vaccine R&D financing.

Read more

Advancing access to monoclonal antibodies in Africa: setting priorities, assessing feasibility, and enabling R&D and manufacturing

This meeting report synthesizes key learnings and recommendations from a 2023 workshop on advancing access to monoclonal antibodies (mAbs) in Africa conducted jointly by the Africa Centres for Disease Control and Prevention and IAVI, with the support of Wellcome. The workshop was held as an official side meeting of the 3rd International Conference of Public Health in Africa.

Read more

Building and Enhancing Policy and Advocacy Skills of Civil Society Organizations, Community Based Organizations, Clinical Research Centers and Institutions in Biomedical Prevention Research — Training Manual

Developed in partnership with key stakeholders, this policy and advocacy training manual is designed to ensure that essential skills are shared and transferred among diverse audiences. Our goal is to build a critical mass of advocates who can influence policies and best practices in HIV prevention research and beyond.

Read more

Access to monoclonal antibodies in Africa: A call to action

A report from IAVI and Impact Global Health evaluating the current state of research and development and access for monoclonal antibodies (mAbs) and related products. The report, funded by Wellcome, is a four-year retrospective on the availability of mAbs and biosimilars globally — with new insights into the African region that could serve as a bellwether for progress globally.

Read more

Broadly neutralizing antibodies and their use in HIV research

Antibodies are natural proteins that the body makes that fight disease. Broadly neutralizing antibodies (bnAbs) are a special kind of antibody that is now being researched to see how they can play a role in HIV prevention.

Read more